BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38500259)

  • 1. Monitoring Drug-Protein Interactions in the Bacterial Periplasm by Solution Nuclear Magnetic Resonance Spectroscopy.
    Razew A; Herail Q; Miyachiro M; Anoyatis-Pelé C; Bougault C; Dessen A; Arthur M; Simorre JP
    J Am Chem Soc; 2024 Apr; 146(13):9252-9260. PubMed ID: 38500259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Carbapenemase BKC-1 from Klebsiella pneumoniae Is Adapted for Translocation by Both the Tat and Sec Translocons.
    Bharathwaj M; Webb CT; Vadlamani G; Stubenrauch CJ; Palmer T; Lithgow T
    mBio; 2021 Jun; 12(3):e0130221. PubMed ID: 34154411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
    Nikaido H; Normark S
    Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability.
    Montaner M; Lopez-Argüello S; Oliver A; Moya B
    Microbiol Spectr; 2023 Feb; 11(1):e0303822. PubMed ID: 36475840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria.
    Sawai T; Yamaguchi A; Hiruma R
    Rev Infect Dis; 1988; 10(4):761-4. PubMed ID: 3055174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Lactamases of gram-negative bacteria: new challenges for new drugs.
    Sanders CC
    Clin Infect Dis; 1992 May; 14(5):1089-99. PubMed ID: 1600011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of beta-lactamases against beta-lactams.
    Stratton CW
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():23-35. PubMed ID: 3062002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of action of beta-lactam antibiotics and problems concerning the development of resistance in antibacterial chemotherapy].
    Semenitz E
    Wien Klin Wochenschr Suppl; 1983; 142():7-11. PubMed ID: 6606272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sch 29482: stability and inhibitory potency towards beta-lactamases from Gram-negative bacteria.
    Pechère JC; Letarte R; Guay R; Asselin C; Morin C
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():123-32. PubMed ID: 6977528
    [No Abstract]   [Full Text] [Related]  

  • 10. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases.
    Caselli E; Powers RA; Blasczcak LC; Wu CY; Prati F; Shoichet BK
    Chem Biol; 2001 Jan; 8(1):17-31. PubMed ID: 11182316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
    Neu HC
    Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
    Lamers RP; Cavallari JF; Burrows LL
    PLoS One; 2013; 8(3):e60666. PubMed ID: 23544160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Lactamases: Why and How.
    Pratt RF
    J Med Chem; 2016 Sep; 59(18):8207-20. PubMed ID: 27232275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of beta-lactamases on the development of novel antimicrobial agents.
    Bush K
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1284-90. PubMed ID: 12498001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics.
    Zimmermann W
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):131-4. PubMed ID: 107128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of beta-lactamase inhibitors into the periplasm of gram-negative bacteria.
    Farmer TH; Degnan BA; Payne DJ
    FEMS Microbiol Lett; 1999 Jul; 176(1):11-5. PubMed ID: 10418127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli.
    Pitout JD; Sanders CC; Sanders WE
    Am J Med; 1997 Jul; 103(1):51-9. PubMed ID: 9236486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for evaluating the outer membrane permeability to beta-lactamase-stable beta-lactam antibiotics.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Mar; 33(3):310-6. PubMed ID: 6991466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.
    Neu HC
    Am J Med; 1985 Nov; 79(5B):2-12. PubMed ID: 3907341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of bacterial resistance to beta-lactams by beta-lactamases].
    Sawai T
    Nihon Rinsho; 1997 May; 55(5):1225-30. PubMed ID: 9155179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.